NRD
ACH

Nebula Research & Development’s Accendra Health ACH Stock Holding History

Nebula Research & Development’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-122,539
Closed -$1.12M – 611
2025
Q2 		$1.12M Sell
122,539
-13,277
-10% -$97.8K 0.09% 365
2025
Q1 		$1.23M Buy
+135,816
New +$1.43M 0.11% 305
2023
Q2 		– Sell
-11,076
Closed -$161K – 422
2023
Q1 		$161K Buy
+11,076
New +$198K 0.28% 188

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nebula Research & Development's ACH Position: Q3 2025 in Review

Nebula Research & Development sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 122,539 shares — an estimated $1.12M sold.

Nebula Research & Development first reported a position in ACH in Q1 2023 and held it in 3 quarters. The position peaked at $1.23M in Q1 2025. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Nebula Research & Development reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 122,539 Accendra Health shares in Q3 2025, an estimated $1.12M.
  • Nebula Research & Development first reported a position in Accendra Health in Q1 2023 and held it in 3 quarters.
  • Nebula Research & Development's Accendra Health position peaked at $1.23M in Q1 2025.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.